Cytomegalovirus disease with atypical presentation in a renal transplant patient: Case report

Experimental and Clinical Transplantation

Volumn 4, Issue 1, 2006, Pages 458-461

  Khosravi, Masoud ^a,c   Nobakht, Ali ^b   Nikokar, Abdolah R ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE   (Iran)

Author keywords

Cytomegalovirus infection; Endothelial cells; Immunosuppression; Kidney transplantation

Indexed keywords

CREATININE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIGEN PP65; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ANOREXIA; ANTIGEN DETECTION; ARTICLE; CASE REPORT; CHILL; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG DOSE REGIMEN; DRUG RESPONSE; EPIGASTRIC PAIN; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEMORRHOID; HEMORRHOIDECTOMY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; KIDNEY GRAFT; LEUKOPENIA; MALAISE; NAUSEA; NEPHROLOGY; NONHUMAN; POSTOPERATIVE PERIOD; THROMBOCYTOPENIA; VIRUS DETECTION; VOMITING;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEMORRHOIDS; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED;

EID: 33745629025     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Pescovitz MD. Prevention and treatment of cytomegalovirus disease in solid organ transplant recipients: the clinical and economic impact of evolving strategies. Introduction. Am J Health Syst Pharm 2003; 60: 53-54
2. Hwang EA, Kang MJ, Han SY, Park SB, Kim HC. Viral infection following kidney transplantation: long-term follow-up in a single center. Transplant Proc 2004; 36: 2118-2119
3. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751
4. Rubin RH, Colvin RB. Impact of cytomegalovirus infection on renal transplantation. In: Racusen LC, Solez K, Burdick JF, eds. Kidney transplant rejection. New York, Marcel Dekker; 1998, pp 605-626
5. Rubin RH, Alexander BD, MD, Tapper ML. New therapeutic options in CMV infection. Available at: http://www.medscape.com Accessed December 30, 2002
6. Pizzo PA. Fever in immunocompromised patients. N Engl J Med 1999; 341: 893-900
7. Renal Week 2002: American Society of Nephrology 35th annual meeting advances in clinical nephrology and renal transplantation. Available at: http://www.medscape.com Accessed December 10, 2002
8. American Transplant Congress. 2003 The Fourth Joint American Transplant Meeting immunosuppression and infection: opposing challenges in solid organ transplantation. Available at: http://www.medscape.com Accessed July 16, 2003
9. Nicholson AC, Hajjar DP. Herpesvirus in atherosclerosis and throm bosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 1998; 18: 339-348
10. Rahbar A, Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 2005; 79: 2211-2220
11. Boobes Y, Al Hakim M, Dastoor H, Bernieh B, Abdulkhalik S. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports. Transplant Proc 2004; 36: 1841-1843.
12. Kulkami AA, Badve SV, Tapiawala SN, Deshpande RB, Shah BV. Cytomegalovirus nasal polyp after renal transplant. J Assoc Physicians India 2003; 51: 614-615
13. Lake KD. New prophylactic treatment strategy for cytomegalovirus disease. Am J Health Syst Pharm 2003; 60: S13-S16